IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ligand Pharmaceuticals Inc

CUSIP: 53220KAH1 | 8 institutional holders

Quarters

Q3 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Wolverine Asset Management LLC50,367,000
0.6% of portfolio›$84.8M
Voya Investment Management LLC28,430,000
0.0% of portfolio›$47.8M
Bank of Montreal21,691,000
0.0% of portfolio›$36.4M
Warberg Asset Management LLC6,750,000
1.5% of portfolio›$11.3M
Citigroup Inc5,599,000
0.0% of portfolio›$9.4M
Calamos Advisors LLC5,138,000
0.0% of portfolio›$8.7M
FMR LLC5,123,000
0.0% of portfolio›$8.6M
AGF Management LTD1,325,000
0.0% of portfolio›$2.2M
Universal- Beteiligungs- und Servicegesellschaft mbH200,000
0.0% of portfolio›$337.7K
StyleTurnoverLocationFiled
Wolverine Asset Management LLC
50,367,000$84.8M0.6%Deep ValueVery HighChicago, IL2026-11-02
Voya Investment Management LLC
28,430,000$47.8M0.0%GrowthMediumAtlanta, GA2026-11-10
Bank of Montreal
21,691,000$36.4M0.0%CoreMediumToronto, Australia2026-11-09
Warberg Asset Management LLC
6,750,000$11.3M1.5%YieldHighWinnetka, IL2026-11-02
Citigroup Inc
5,599,000$9.4M0.0%CoreMediumNew York, NY2026-11-04
Calamos Advisors LLC
5,138,000$8.7M0.0%CoreMediumNaperville, IL2026-11-02
FMR LLC
5,123,000$8.6M0.0%GrowthMediumBoston, MA2026-11-10
AGF Management LTD
1,325,000$2.2M0.0%MomentumHighToronto, Australia2026-11-03
Universal- Beteiligungs- und Servicegesellschaft mbH
200,000$337.7K0.0%CoreLowFrankfurt Am Main, Hong Kong2026-11-10